These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26292757)

  • 1. An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress.
    Quereda V; Porlan E; Cañamero M; Dubus P; Malumbres M
    Cell Death Differ; 2016 Mar; 23(3):430-41. PubMed ID: 26292757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.
    Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M
    Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors.
    Cerqueira A; Martín A; Symonds CE; Odajima J; Dubus P; Barbacid M; Santamaría D
    Mol Cell Biol; 2014 Apr; 34(8):1452-9. PubMed ID: 24515438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases.
    Barbacid M; Ortega S; Sotillo R; Odajima J; Martín A; Santamaría D; Dubus P; Malumbres M
    Cold Spring Harb Symp Quant Biol; 2005; 70():233-40. PubMed ID: 16869759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D; Mahony D; Wills K; Lees E
    Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
    Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
    Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
    Bagui TK; Jackson RJ; Agrawal D; Pledger WJ
    Mol Cell Biol; 2000 Dec; 20(23):8748-57. PubMed ID: 11073976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
    Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
    Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.
    Rodríguez-Díez E; Quereda V; Bellutti F; Prchal-Murphy M; Partida D; Eguren M; Kollmann K; Gómez de Cedrón M; Dubus P; Cañamero M; Martínez D; Sexl V; Malumbres M
    Blood; 2014 Oct; 124(15):2380-90. PubMed ID: 25157181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.
    Bagui TK; Mohapatra S; Haura E; Pledger WJ
    Mol Cell Biol; 2003 Oct; 23(20):7285-90. PubMed ID: 14517297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of mice without Cip/Kip CDK inhibitors.
    Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
    Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines.
    Sangfelt O; Erickson S; Einhorn S; Grandér D
    Oncogene; 1997 Jan; 14(4):415-23. PubMed ID: 9053838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
    Green SL; Freiberg RA; Giaccia AJ
    Mol Cell Biol; 2001 Feb; 21(4):1196-206. PubMed ID: 11158306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of high glucose on the Cip/Kip family expression profiles in HRECs.
    Tian J; Ma H; Luo Y; Hu A; Lin S; Li T; Guo K; Li J; Cai M; Tang S
    J Mol Histol; 2013 Dec; 44(6):705-13. PubMed ID: 23636608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
    Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M
    EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.